Rheumatology
Early RA synovium splits into two expression/histology groups
Open access · cc by · source: Europe PMC
Targeted knee synovial biopsies from early RA patients clustered into two major gene-expression groups with different histological scores, showing molecular heterogeneity even early in disease.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
GSK2982772 (RIPK1) looked similar to placebo on RA activity at tested exposures.
In a 52-patient placebo-controlled experimental-medicine study on stable csDMARDs, safety was primary and DAS28-CRP/ACR outcomes were similar between GSK2982772 and placebo — authors conclude no meaningful clinical improvement at evaluated exposures.
Scope note — tissue heterogeneity biology, not a drug RCT
Limits the claim's scope: a different population, assay, or outcome.
Early RA synovium already shows two expression/histology clusters.
Targeted arthroscopic biopsies from early RA clustered into two major gene-expression groups with different histological scores — molecular heterogeneity early in disease, not a treatment-assignment tool by itself.
Evidence for the claim as stated.
A null RIPK1 activity signal, an MTD for seliciclib, and early synovium clusters are different evidence types. Pathway interest does not transfer efficacy across programmes.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
A null RIPK1 activity signal, an MTD for seliciclib, and early synovium clusters are different evidence types. Pathway interest does not transfer efficacy across programmes.
Study at a glance
- Design
- Other — Arthroscopic targeted synovial biopsy histopathology + expression clustering
- N
- N=16 · 12 early RA (<1 year) and 4 long-standing RA; 18 samples from 16 cases
- Population
- Adults with early or long-standing rheumatoid arthritis undergoing targeted synovial biopsy
- Outcome
- Histopathology and gene-expression subgroups of synovitis
Structured fields used in claim comparison tables when every cited study has a complete layer.
Inspect source passages
Early RA synovium splits into two expression/histology groups
These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.
How were early RA synovial samples obtained?
Synovial tissues were obtained from knee joints of 12 patients with early RA by targeted biopsy under arthroscopy
Who else was included?
12 patients with early RA (duration of less than 1 year before the diagnosis), and 4 with long-standing RA
Key findings
Eighteen samples from 16 cases formed two major expression groups. Group II vs I showed 180 genes up and 235 down (Q<5%), with significant histological score differences between groups — evidence that early RA synovitis is not one molecular state.
Methodology
Authors obtained arthroscopic targeted synovial biopsies from 12 early RA patients (<1 year) and 4 long-standing RA patients, then compared histopathology with gene-expression clustering.
Limitations
Two clusters in a small biopsy series do not define treatment arms. Arthroscopic knee samples may not represent every joint. Expression differences are associative with histology, not proven drug targets by themselves.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- Are people with autoimmune diseases more prone to blood clots?
- Do forums and game features make a health website work better?
- RIPK1 inhibitor GSK2982772 did not beat placebo on RA activity here
- Seliciclib MTD is 400 mg in TNF-refractory RA (TRAFIC phase 1b)
- Can gastrodin calm RA by blocking histone lactylation?